Sangamo Therapeutics (SGMOQ) FCF Margin Growth (1y) (2011 - 2025)
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) FCF Margin Growth (1y) (2011 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.28 Bn | 9.43 Bn | 112.79 Mn | 682.00 |
| 2 | CRISPR Therapeutics AG | 5.20 Bn | 5.20 Bn | - | 1.20 Mn |
| 3 | Iovance Biotherapeutics | 3.76 Bn | 3.46 Bn | 55.72 Mn | 5,823.00 |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | -189.00 |
| 5 | uniQure | 3.07 Bn | 3.07 Bn | 5.49 Mn | 26,580.00 |
| 6 | Beam Therapeutics | 2.67 Bn | 2.67 Bn | - | -1.30 Mn |
| 7 | Precigen | 2.43 Bn | 2.43 Bn | 52.17 Mn | 226,818.00 |
| 8 | Sarepta Therapeutics | 2.34 Bn | 1.54 Bn | 251.87 Mn | 1,141.00 |
| 9 | Vericel | 2.00 Bn | 1.83 Bn | 56.40 Mn | 1,854.00 |
| 10 | Sangamo Therapeutics | 43.15 Mn | 22.20 Mn | - | -12,194.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -12,194.00 |
| Sep 30, 2025 | -492,664.00 |
| Jun 30, 2025 | 744,564.00 |
| Mar 31, 2025 | 980,282.00 |
| Dec 31, 2024 | 255,605.00 |
| Sep 30, 2024 | 55,631.00 |
| Jun 30, 2024 | -657,481.00 |
| Mar 31, 2024 | -1.02 Mn |
| Dec 31, 2023 | -236,877.00 |
| Sep 30, 2023 | -31,311.00 |
| Jun 30, 2023 | -76,700.00 |
| Mar 31, 2023 | 17,053.00 |
| Dec 31, 2022 | -3,838.00 |
| Sep 30, 2022 | 695.00 |
| Jun 30, 2022 | 1,237.00 |
| Mar 31, 2022 | 7,214.00 |
| Dec 31, 2021 | -16,638.00 |
| Sep 30, 2021 | -27,657.00 |
| Jun 30, 2021 | -94,344.00 |
| Mar 31, 2021 | -11,776.00 |